A company providing genetically engineered insects to control threats to health and agriculture is designing a modified moth that now destroys soybeans and other crops. . . . → Read More: Engineered Moth to Control Soybean Pest
|
|||||
|
|
Two biotechnology companies plan to develop new therapies mainly for eye and neurological diseases that silence genes responsible for those conditions. . . . → Read More: Biotechs Partner on Gene Silencing in $1.1B Deal 
Two biotechnology enterprises working in genome editing and regenerative medicine are sharing their technologies to develop off-the-shelf cell therapies. . . . → Read More: Biotechs Join Forces for Off-the-Shelf Stem Cells  One comment - (Comments are closed)  Intellectual property, Joint ventures/collaborations  biomedical, biotechnology, clinical trials, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, preclinical, university 
Techniques analyzing data from across the genome that reveal risks of diseases, better predict disorders in the main ethnicity of the population studied than other ethnic groups. . . . → Read More: Genetic Risk Analysis Shows Ethnic Bias One comment - (Comments are closed) New products Asia, biomedical, genomics, health care, Japan, life sciences, mathematics, medical device, physical sciences, U.K., university 
A biotechnology company developing treatments for disease and enhanced agricultural products with genome editing is raising $126 million in its initial public offering, or IPO, of common stock. . . . → Read More: Genome Editing Biotech Raises $126M in IPO Comments are closed Finance agriculture, biomedical, biotechnology, cancer, equity, genomics, investment, IPO, life sciences, pharmaceuticals 
A new company is licensing technology from the lab of its co-founder at Harvard University to develop stem cell therapies for any recipients, without causing immune reactions. . . . → Read More: Start-Up Creating Off-the-Shelf Stem Cell Therapies One comment - (Comments are closed) Intellectual property, New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, stem cells, university, venture capital 
A lab studying DNA from past civilizations and the genomics technology company Illumina are investigating remains of ancient peoples for insights into today’s neurological disorders. . . . → Read More: Ancient DNA Studied for Mental Health Clues One comment - (Comments are closed) Joint ventures/collaborations biomedical, engineering, Europe, genomics, life sciences, mathematics, medical device, physical sciences, psychiatric, university 
Sherlock Biosciences Inc., a new enterprise offering medical diagnostics based on the genome-editing technology Crispr, is starting up with $35 million in seed financing. . . . → Read More: Crispr Diagnostics Company Launches with $35M Funding Comments are closed Intellectual property, New products biomedical, biotechnology, engineering, entrepreneurs, genomics, investment, licensing, life sciences, medical device, university 
The Bill and Melinda Gates Foundation is enlisting a company that discovers therapeutic antibodies to help researchers develop new drugs and vaccines for serious infectious diseases. . . . → Read More: Gates Supporting Infectious Antibody Discovery Comments are closed Finance, Joint ventures/collaborations biomedical, biotechnology, Canada, engineering, genomics, grant, life sciences, pharmaceuticals 
A biotechnology company in the U.K. and U.S. software maker Microsoft are collaborating on new processes to speed development of gene and cell therapies. . . . → Read More: Microsoft, Biotech Partner on Gene, Cell Therapies One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, computer science, engineering, genomics, life sciences, manufacturing, mathematics, pharmaceuticals, physical sciences, software, U.K. |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||